Shanghai Fosun Pharmaceutical (Group) Co (Shanghai Fosun Pharmaceutical (Group) Co) Change In Receivables : $0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Change In Receivables?

Shanghai Fosun Pharmaceutical (Group) Co's change in receivables for the quarter that ended in Mar. 2024 was $0 Mil. It means Shanghai Fosun Pharmaceutical (Group) Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Shanghai Fosun Pharmaceutical (Group) Co's change in receivables for the fiscal year that ended in Dec. 2023 was $225 Mil. It means Shanghai Fosun Pharmaceutical (Group) Co's Accounts Receivable declined by $225 Mil from Dec. 2022 to Dec. 2023 .

Shanghai Fosun Pharmaceutical (Group) Co's Accounts Receivable for the quarter that ended in Mar. 2024 was $1,033 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 66.82.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shanghai Fosun Pharmaceutical (Group) Co's liquidation value for the three months ended in Mar. 2024 was $-4,438 Mil.

Shanghai Fosun Pharmaceutical (Group) Co Change In Receivables Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Change In Receivables Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-123.08

-238.55

-281.82

-297.85

224.80

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Shanghai Fosun Pharmaceutical (Group) Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

Shanghai Fosun Pharmaceutical (Group) Co (OTCPK:SFOSF) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shanghai Fosun Pharmaceutical (Group) Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1032.801	/	1410.436	*	91
=	66.82

2. In Ben Graham's calculation of liquidation value, Shanghai Fosun Pharmaceutical (Group) Co's accounts receivable are only considered to be worth 75% of book value:

Shanghai Fosun Pharmaceutical (Group) Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2085.817	-	7805.334	+	0.75 * 1032.801	+	0.5 * 1012.941
=	-4,438

Shanghai Fosun Pharmaceutical (Group) Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co (Shanghai Fosun Pharmaceutical (Group) Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (OTCPK:SFOSF) » Definitions » Change In Receivables

Traded in Other Exchanges

02196:Hong Kong 08HH:Germany 08HH:Germany 600196:China

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.